2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
Interest Income | 27,862,000 | 2.332% | 27,227,000 | 15,252,000 | 10,246,000 | 12,292,000 |
Interest Expense | (21,496,000) | 10.474% | (19,458,000) | (7,659,000) | (3,448,000) | (5,440,000) |
Net Interest Income | 6,366,000 | -18.059% | 7,769,000 | 7,593,000 | 6,798,000 | 6,852,000 |
Other Operating Income | 13,177,000 | 28.556% | 10,250,000 | 8,725,000 | 7,903,000 | 7,902,000 |
Total Operating Income | 19,543,000 | 8.458% | 18,019,000 | 16,318,000 | 14,701,000 | 14,754,000 |
Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
Net Operating Income | 19,543,000 | 8.458% | 18,019,000 | 16,318,000 | 14,701,000 | 14,754,000 |
Operating Expenses | (12,502,000) | 8.233% | (11,551,000) | (10,913,000) | (10,924,000) | (10,380,000) |
Impairment Losses on Loans & Advances | (547,000) | 7.677% | (508,000) | (836,000) | (254,000) | (2,325,000) |
Other Impairment Losses | 0 | -- | 0 | 0 | 0 | 0 |
Operating Profit / (Loss) | 6,494,000 | 8.960% | 5,960,000 | 4,569,000 | 3,523,000 | 2,049,000 |
Change in FV & Impairment on Inv. Prop. | -- | -- | (12,000) | (50,000) | (106,000) | (132,000) |
Change in FV & Impairment on Others | (588,000) | -40.964% | (996,000) | (389,000) | (266,000) | (455,000) |
Profit / (Loss) on Disposal | -- | -- | 0 | 0 | 0 | 0 |
Other Non-operating Items | -- | -- | 0 | 0 | 0 | 0 |
Share of Results of Asso. & JCEs | 108,000 | -23.404% | 141,000 | 156,000 | 196,000 | 151,000 |
Profit / (Loss) before Taxation | 6,014,000 | 18.084% | 5,093,000 | 4,286,000 | 3,347,000 | 1,613,000 |
Taxation | (1,972,000) | 20.907% | (1,631,000) | (1,384,000) | (1,034,000) | (862,000) |
Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | 8,000 | 14.286% | 7,000 | 46,000 | 2,000 | (27,000) |
Others | -- | -- | -- | -- | -- | -- |
Profit / (Loss) Attributable to Shareholders | 4,050,000 | 16.748% | 3,469,000 | 2,948,000 | 2,315,000 | 724,000 |
2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
Depreciation & Amortisation | 1,126,000 | 5.135% | 1,071,000 | 1,186,000 | 1,181,000 | 1,251,000 |
Directors' Emoluments | -- | -- | -- | -- | -- | -- |
2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
EPS (cts) | 141.300 | 30.110% | 108.600 | 85.900 | 61.300 | 10.400 |
DPS (cts) | 37.000 | -- | 27.000 | 18.000 | 12.000 | 9.000 |
Dividend Payout Ratio (%) | 26.185% | -- | 24.862% | 20.955% | 19.576% | 86.538% |
Cash flow per share ($) | (8.057) | -- | (2.002) | 5.116 | 3.931 | 6.720 |
NBV per share ($) | 18.294 | -- | 16.677 | 14.910 | 14.943 | 14.538 |
Remarks: | Real time quote last updated: 04/03/2025 17:06 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (K$) | USD 4,050,000 |
%Change | 16.748% |
EPS / (LPS) | USD 1.413 |
NBV Per Share ($) | USD 18.294 |